Weiss Multi-Strategy Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,000	Closed	-$7.83M	–	796
2022 Q1	$7.83M	Buy	30,000 +28,000	+1,400%	+$6.65M	0.18%	195
2021 Q4	$439K	Buy	+2,000	New	+$389K	0.01%	559
2021 Q3	–	Sell	-5,000	Closed	-$1.01M	–	810
2021 Q2	$1.01M	Buy	+5,000	New	+$1.05M	0.02%	486
2014 Q3	–	Sell	-14,100	Closed	-$1.33M	–	754
2014 Q2	$1.33M	Buy	+14,100	New	+$989K	0.03%	383

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Weiss Multi-Strategy Advisers's VRTX Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Vertex Pharmaceuticals (VRTX) in Q1 2024, closing a stake of 29,375 shares — an estimated $12M sold.

Weiss Multi-Strategy Advisers first reported a position in VRTX in Q2 2013 and held it in 42 quarters. The position peaked at $20.7M in Q2 2023. 1,493 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Vertex Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 29,375 Vertex Pharmaceuticals shares in Q1 2024, an estimated $12M.
Weiss Multi-Strategy Advisers first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 42 quarters.
Weiss Multi-Strategy Advisers's Vertex Pharmaceuticals position peaked at $20.7M in Q2 2023.
1,493 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.